TheStreet, Inc. (TST) Declares $0.025 Quarterly Dividend; 5.7% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
TheStreet, Inc. Announces Quarterly Dividend
August 31, 2015 4:01 PM EDTNEW YORK, Aug. 31, 2015 /PRNewswire/ -- TheStreet, Inc. (NASDAQ: TST), a leading digital financial media company, announced today that its board of directors has declared a quarterly cash dividend on the Company's common stock. The cash dividend of $0.025 per share of common stock will be payable on September 30, 2015 to all shareholders of... More
Telesta Receives FDA BLA Filing Notification Letter and Priority Review Designation for MCNA(1)
August 28, 2015 1:23 PM EDTMONTREAL, Aug. 28 2015 /PRNewswire/ - Telesta Therapeutics Inc. (TSX: TST) (PNK: BNHLF) announced today that it has received its BLA Filing Notification for MCNA from the U.S. Food and Drug Administration (FDA). This formal letter communicates that the FDA has completed its initial review of Telesta's Biologics License Application (BLA) submitted on June 29, 2015 and has accepted it for filing. In the same letter, the FDA communicated that it has designated the file for 6 month Priority Review and has set February 27,... More
